HIV

Sangamo shares in biotech spotlight
Marketwatch
Fri, 02/25/11 - 03:44 pm
Sangamo BioSciences
HIV
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
The Silver Lining to Idenix's Bad News
Minyanville
Fri, 02/11/11 - 12:17 pm
Idenix
GSK
HIV
Some Drugmakers Hold Talks With The Patent Pool
Pharmalot
Fri, 02/11/11 - 12:09 pm
patents
HIV
Gilead Sciences
Sequoia
ViiV Healthcare
GSK
Pfizer
Medicines Patent Pool
Gilead refiles for approval of HIV drug
Bizjournals.com
Fri, 02/11/11 - 07:46 am
HIV
Gilead Sciences
Truvada
Idenix Falls as FDA Places Hold on HIV Drug, Releases Another
Bloomberg
Thu, 02/10/11 - 10:00 am
Idenix
FDA
HIV
GSK
ViiV Healthcare
Bionor Will Conduct Further Trials of HIV Vaccine, CEO Says
Bloomberg
Fri, 02/4/11 - 11:06 am
Bionor Pharma
HIV
vaccines
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Mon, 01/31/11 - 07:57 am
Mylan
Matrixx
HIV
antiretrovirals
Tibotec
TMC278
Gilead's HIV Drug: FDA Returns to Sender
TheStreet.com
Tue, 01/25/11 - 06:03 pm
HIV
FDA
Gilead Sciences
B-tripla
Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189
BusinessWire
Sun, 01/9/11 - 06:11 pm
Inhibitex
INX-189
anti-viral
HIV
hepatitis C
OraSureTechnologies: A Biotech Company Poised to Revolutionize Two Markets
Fri, 01/7/11 - 12:07 pm
OraSure
diagnostics
HIV
hepatitis C
Oraquick
Natco Seeks Pfizer’s Approval to Sell Replica Drugs, Times Says
Bloomberg
Tue, 01/4/11 - 09:29 pm
Natco
Pfizer
generics
HIV
India
J&J Overcharged for Medications, AIDS Treatment Group Alleges in Lawsuit
Bloomberg
Wed, 12/22/10 - 09:50 pm
JNJ
AIDS
HIV
Bristol-Myers buys rights to potential HIV drug in deal that could be worth up to $286 million
Yahoo/AP
Mon, 12/20/10 - 11:51 am
HIV
Bristol-Myers Squibb
Oncolys BioPharma
80% Market Share In HIV Pharmaceutical Sector And Unappreciated Pipeline Make Gilead Sciences (GILD) A Contrarian Stock Pick From These Saint Louis Porfolio Managers
Yahoo/Wall Street Transcript
Sun, 12/5/10 - 11:48 am
Gilead Sciences
HIV
An Innovator’s Dilemma For Merck AIDS Drug
Forbes
Mon, 11/29/10 - 11:24 am
Merck
HIV
AIDS
Isentress
Gilead: Preventing HIV Infection With a Pill
Seeking Alpha
Sun, 11/28/10 - 11:32 am
Gilead Sciences
HIV
Truvada
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Fierce Pharma
Tue, 11/23/10 - 10:40 am
Gilead Sciences
Truvada
HIV
Orasure gains on HIV test update
Mon, 11/22/10 - 03:47 pm
OraSure
HIV
diagnostics
Oraquick
J&J, U.S. Sue Mylan and Lupin to Block Generic Copy of HIV Drug
Bloomberg
Thu, 11/18/10 - 06:39 pm
Lupin
generics
Mylan
JNJ
Prezista
HIV

Pages